1. Mayer AS, Stoller JK, Bucher Bartelson B, Ruttenber J, Sanhaus RA, Newman LS. Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med 2000, 162:553-8.

An important study that was derived from Registry participants was published this spring in the American Review of Respiratory and Critical Care Medicine. This study examined whether occupational exposures to mineral dust, fumes, or smoke contribute to cough or low lung function in Alpha-1. The findings are strong evidence that a clean air environment is important to lung health for individuals with Alpha-1. For full abstract at the National Library of Medicine.

2. Stoller JK, Brantley M, Fleming LE, Bean JA, Walsh J. Formation and current results of a patient-organized registry for alpha(1)-antitrypsin
deficiency. Chest 2000; 118(3):843-8.

This description is interesting reading for Registry participants since it shows how diverse a population the Alpha-1 community is and compares the current registry to the National Institute of Health Registry that ended in 1996. For full abstract at the National Library of Medicine.

3. Mullins CD, Huang X, Merchant S, Stoller JK. The Direct Medical Costs of Alpha-1 Antitrypsin Deficiency. Chest 2001; 119(3): 745-752

The findings suggest that Alpha-1 is an expensive disease for those with severely depressed lung function and that the major cost of illness is the cost of hospitalization.

4. Baker RD, Rosenthal P, Sherman P. Alpha-1 Foundation Research Registry: From the past to the Future. Journal of Pediatric Gastroenterology and Nutrition 2002; 34:1-4

5. Strange, C.,Dickson, MR; Carter, CL Carpenter, MJ.; Holladay, B.; Lundquist, R.; Brantly, ML (2004) Genetic testing for Alpha1-antitrypsin deficiency. Genet Med. 6(4): 204-211

Results of the Alpha Coded Testing Study.